triple glp-1/gip/glucagon receptor agonist Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 Effects, working principles and target
Description
& Eldeghaidy, S
As relatively new classes of diabetes medications, GLP-1RA and SGLT2 agents are available as branded products with no generic equivalents
[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z, et al
April 2016
2020;5:e133429
